NASDAQ : XOMA
XOMA Royalty Corporation — Key statistics
Healthcare · Biotechnology · United States
Last price 40.17 USD (At close: Jul 13, 2026) · Market cap 710.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 710.16M |
| Enterprise Value | 748.79M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 17.68M |
| Shares Outstanding | 17.68M |
| Shares Change (YoY) | +51.64% |
| Shares Change (QoQ) | -3.75% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 42.37% |
| Float | 6.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 25.49 |
| Forward PE | n/a |
| PS Ratio | 14.63 |
| Forward PS | 15.89 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 14.50 |
| P/FCF Ratio | 104.53 |
| P/OCF Ratio | 104.53 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 37.57 |
| EV / Sales | 15.42 |
| EV / EBITDA | 90.27 |
| EV / EBIT | 150.51 |
| EV / FCF | 110.21 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.59 |
| Quick Ratio | 3.31 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 14.38 |
| Debt / FCF | 18.36 |
| Interest Coverage | 0.38 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 34.23% |
| Return on Assets (ROA) | 1.28% |
| Return on Invested Capital (ROIC) | 3.27% |
| Return on Capital Employed (ROCE) | 2.08% |
| Weighted Average Cost of Capital (WACC) | 9.21% |
| Revenue Per Employee | $3.47M |
| Profits Per Employee | $1.42M |
| Employee Count | 14 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 104,000 |
| Effective Tax Rate | 0.31% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +48.01% |
| 50-Day Moving Average | 42.06 |
| 200-Day Moving Average | 33.70 |
| Relative Strength Index (RSI) | 34.34 |
| Average Volume (20 Days) | 442,640 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 914,936 |
| Short Previous Month | 898,917 |
| Short % of Shares Out | 5.18% |
| Short % of Float | 13.53% |
| Short Ratio (days to cover) | 6.43 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 48.56M |
| Gross Profit | 48.09M |
| Operating Income | 4.98M |
| Pretax Income | 33.91M |
| Net Income | 19.93M |
| EBITDA | 8.30M |
| EBIT | 4.98M |
| Earnings Per Share (EPS) | $1.58 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 86.09M |
| Total Debt | 124.73M |
| Net Cash | -38.64M |
| Net Cash Per Share | -$2.19 |
| Equity (Book Value) | 112.90M |
| Book Value Per Share | 7.79 |
| Working Capital | 85.67M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 6.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.32M |
| Net Borrowing | -11.92M |
| Free Cash Flow | 6.79M |
| FCF Per Share | $0.38 |
Margins
| Measure | Value |
|---|
| Gross Margin | 99.04% |
| Operating Margin | 10.25% |
| Pretax Margin | 69.85% |
| Profit Margin | 69.63% |
| EBITDA Margin | 17.08% |
| EBIT Margin | 10.25% |
| FCF Margin | 13.99% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -51.64% |
| Shareholder Yield | -51.64% |
| Earnings Yield | 2.81% |
| FCF Yield | 0.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $39.00 |
| Price Target Difference | -2.91% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 5.48% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 18, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.35 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |